Between December 1st 1997 and November 30th 1998 there were no new subjects enrolled into this study. Four follow up studies were performed. The last follow up study was completed by March 1998, and data analysis is now (as of February 1999) complete. Based on this pilot study of the growth and nutrition of children with intractable epilepsy on the ketogenic diet we conclude the following. Preliminary Studies Aim 1: To determine the efficacy of the standard 4:1 ketogenic diet (KD) As part of a pilot study of the growth and nutritional status of children on the currently recommended 4:1 KD preceded by a fast, efficacy was measured. Twenty-five subjects with intractable epilepsy were enrolled over a two-year time interval and followed prospectively for 6 months. Follow-up evaluations were scheduled at 1, 3 and 6 months. We defined efficacy as >50%reduction of baseline seizure frequency. Change in seizure frequency was tabulated from the parent's daily seizure calendars and the average seizure frequency (number of seizures per week) occurring during 28 days before the 3-and 6-month follow-up visits were compared with baseline. The percentage decrease in seizures from baseline was used to assess the efficacy of the diet. Adverse events were also noted.
Aim 2 : To determine if the restrictive nature of the KD places the children at risk for nutritional deficiencies that will impair growth rate and accretion of fat-free mass. The second project was a longitudinal study of growth and nutritional status of children with intractable epilepsy treated with the KD. The same 25 subjects were followed at baseline, 1-month, 3-months and 6-months on the KD treatment. Weights and heights were obtained and measurements were converted to Z scores. Body composition was obtained using the dual energy x-ray absorptiometry (DXA) and expressed as fat-free mass (FFM) (lean mass + bone mass) and % body fat.
Aim 3 : To determine if children on the ketogenic diet are at risk for osteopenia. It is well known that anticonvulsants may predispose children to osteopenia through alterations in vitamin D and calcium metabolism. Whether the KD worsens this effect has not been well studied. We evaluated bone health in 14 of the 25 children by measuring Lumbar AP spine bone density (BMD) and bone mineral content (BMC) before the KD and at 3 months into the maintenance diet.
Aim 4 : To determine if change in substrate utilization as measured by the respiratory quotient (RQ) can predict who will respond to treatment with the ketogenic diet. The mechanism of the KD remains unknown. The currently recommended KD protocol at CHOP requires a 3 month commitment (because of some late responders) before efficacy can be determined. A predictor of response would simplify the management of these patients. We measured Resting Energy Expenditure (REE) and RQ in the previously described 25 subject to see if changes in substrate utilization as measure by the RQ could predict response to KD.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
3M01RR000240-35S1
Application #
6219817
Study Section
Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
35
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Medina-Gomez, Carolina; Kemp, John P; Dimou, Niki L et al. (2017) Bivariate genome-wide association meta-analysis of pediatric musculoskeletal traits reveals pleiotropic effects at the SREBF1/TOM1L2 locus. Nat Commun 8:121
Agopian, A J; Goldmuntz, Elizabeth; Hakonarson, Hakon et al. (2017) Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects. Circ Cardiovasc Genet 10:e001449
Ruan, Alexandra; Tobin, Nicole H; Mulligan, Kathleen et al. (2016) Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021. J Acquir Immune Defic Syndr 72:372-5
Medoff-Cooper, Barbara; Irving, Sharon Y; Hanlon, Alexandra L et al. (2016) The Association among Feeding Mode, Growth, and Developmental Outcomes in Infants with Complex Congenital Heart Disease at 6 and 12 Months of Age. J Pediatr 169:154-9.e1
Ollberding, Nicholas J; Gilsanz, Vicente; Lappe, Joan M et al. (2015) Reproducibility and intermethod reliability of a calcium food frequency questionnaire for use in Hispanic, non-Hispanic Black, and non-Hispanic White youth. J Acad Nutr Diet 115:519-27.e2
Medina-Gómez, Carolina; Chesi, Alessandra; Heppe, Denise H M et al. (2015) BMD Loci Contribute to Ethnic and Developmental Differences in Skeletal Fragility across Populations: Assessment of Evolutionary Selection Pressures. Mol Biol Evol 32:2961-72
Avitabile, Catherine M; Goldberg, David J; Zemel, Babette S et al. (2015) Deficits in bone density and structure in children and young adults following Fontan palliation. Bone 77:12-6
Rutstein, Richard M; Samson, Pearl; Fenton, Terry et al. (2015) Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020A. Pediatr Infect Dis J 34:162-7
Trabulsi, Jillian C; Irving, S Y; Papas, M A et al. (2015) Total Energy Expenditure of Infants with Congenital Heart Disease Who Have Undergone Surgical Intervention. Pediatr Cardiol 36:1670-9
Lappe, Joan M; Watson, Patrice; Gilsanz, Vicente et al. (2015) The longitudinal effects of physical activity and dietary calcium on bone mass accrual across stages of pubertal development. J Bone Miner Res 30:156-64

Showing the most recent 10 out of 455 publications